+612 9045 4394
 
CHECKOUT
The Drug Free Workplace : How to Get There and Stay There - John Fay

The Drug Free Workplace

How to Get There and Stay There

By: John Fay

Paperback Published: 1st December 1999
ISBN: 9780750671873
Number Of Pages: 552

Share This Book:

Paperback

RRP $110.95
$106.95
or 4 easy payments of $26.74 with Learn more
Ships in 7 to 10 business days

This is a no-nonsense, practical book for helping organizations rid their workplaces of drug abuse and its serious and costly consequences. The book draws upon the collective experiences of hundreds of organizations that have said "no more, not here" and have grown stronger as a result. The path to a drug-free working environment is straight but narrow. The Drug-Free Workplace:
How to Get There and Stay There delineates the path, always with a view toward avoiding missteps that can lead to trouble.
Bringing a workplace back to safety and profitability is a collaborative and multi-disciplinary effort. Participation necessarily involves professionals from security, safety, human resources, and health. Central to the effort is an enlightened management. Every specialist and manager committed to developing and maintaining a drug-free workplace will find in the pages of this book a wealth of sensible, meaningful information.
A drug-free workplace program cuts costs, increases productivity, reduces loss and wastage, avoids accidents, and literally saves careers, families, and lives. Much is at stake, making the drug-free program deserving of thoughtful deliberation, considerable planning, and careful implementation. Preliminary to the process is understanding the key tasks. All of the tasks are spelled out in this book.


Offers organizations a clear course to enact drug policiesTeaches the ramifications of testing and investigating drug use and abuseAddresses liability issues to keep buisness owners, security managers, and their companies out of court

Fay presents a convincing argument for establishing comprehensive programs to combat the substance abuse problem... - Security Management, August 2000

The Rationale for a Drug-Free Workplacep. 1
Hidden Costsp. 3
The Good Newsp. 5
When a Drug-Free Workplace Is Mandatoryp. 6
Damage Reductionp. 8
The Changing Face of Drug Abusep. 8
An Overview of a Drug-Free Programp. 11
Writing a Policyp. 12
Raising Employee Awarenessp. 13
Involving Supervisorsp. 14
Providing Employee Assistancep. 15
Drug Testingp. 16
Assess the Problemp. 19
Examine the Symptomsp. 20
The Anonymous Questionnairep. 20
Observe and Listenp. 21
Diagnosis Through Drug Screeningp. 21
The Undercover Routep. 21
Doing the Homeworkp. 22
Prepare an Action Planp. 22
Policy Considerationsp. 23
Employee Awarenessp. 23
Supervisory Involvementp. 23
Employee Assistancep. 23
Testingp. 24
Program Evaluationp. 24
Apply the Toolsp. 24
Form a Task Forcep. 25
Write the Policyp. 27
Essential Policy Elementsp. 28
Determine Organizational Necessityp. 28
Define the Termsp. 29
Identify the Affected Jobsp. 31
Describe the Prohibited Activitiesp. 32
Name the Enforcement Actionsp. 32
Assign Responsibilitiesp. 33
Identify the Penalties for Violationsp. 33
Identify Treatment and Rehabilitation Benefitsp. 34
The Working Draftp. 35
Your Unique Characteristicsp. 35
A Right and an Obligationp. 40
The Centrality of Testingp. 42
Blueprint Your Policy With a Worksheetp. 45
A Sample Policyp. 58
Communicate the Policyp. 77
Notices and Acknowledgmentsp. 78
Obtain Buy-Inp. 86
Develop Awarenessp. 89
Influencing Employee Behaviorsp. 89
Influencing Employee Attitudesp. 90
Drug Abuse Awarenessp. 91
Formulating the Messagep. 91
Presenting the Messagep. 92
Involve Supervisorsp. 95
The Supervisor's Central Rolep. 95
Leadershipp. 96
Inspire Respectp. 97
Interact with Subordinatesp. 97
Criticize Positivelyp. 97
Be Up Front With Peoplep. 97
Early Involvementp. 98
How to Lookp. 99
What to Look Forp. 100
Performance Indicatorsp. 100
Behavior Indicatorsp. 101
General Indicatorsp. 102
What To Do When Abuse Is Indicatedp. 104
Actions to Takep. 105
Making Referralsp. 106
The Drug-Dependent Employeep. 107
The Addicted Employeep. 108
Addiction Is Not Uncommonp. 108
Everyone Is Vulnerablep. 109
Prevention of Accidentsp. 109
Impediments to Actionp. 109
Rationalizingp. 110
Blockingp. 110
Enablingp. 110
Denialp. 111
Supporting Knowledgep. 112
The Bottom Line Connectionp. 113
Absenteeismp. 113
Insist On Notificationp. 114
Keep a Recordp. 114
Make a Statementp. 114
Take Corrective Actionp. 114
A Framework for Guidancep. 115
Avoid Labelsp. 116
Document the Interventionp. 117
Meeting With the Troubled Employeep. 122
Concepts Important to Supervisionp. 123
Reasonable Causep. 123
Two Supervisors Rulep. 124
Is Impairment Present?p. 125
Are the Facts Reliable?p. 125
Are the Facts Explainable?p. 125
Is the Impairment Present Now?p. 125
Consent to Testp. 126
Search with Implied Consentp. 126
Contrabandp. 126
Amnestyp. 127
Detectable Amountp. 127
Chain of Custodyp. 127
Training Outcomes for Supervisorsp. 128
Conclusionp. 129
Drug Testingp. 131
Starting a Drug Testing Programp. 131
The Fundamentalsp. 132
Applicant Testingp. 134
Reasonablenessp. 134
Impairmentp. 135
Accuracy and Reliabilityp. 135
Quality Assurancep. 136
Testing Methodsp. 136
Sensitivity and Cutoffp. 137
False Positivep. 137
The Need to Use Quality Testingp. 138
Passive Inhalationp. 139
Time of Previous Drug Usep. 139
Can a Pattern of Abuse Be Determined?p. 139
Detection Times for Hard Drugsp. 140
Detection Time for Marijuanap. 140
Liquid Intakep. 140
Test Reportsp. 141
Nanograms and Microgramsp. 141
Legal Issues in Drug Testingp. 142
Conclusionp. 143
Employee Assistance Program (EAP)p. 145
Backgroundp. 145
EAP Staffingp. 148
Drug Program Coordinatorp. 148
Employee Assistance Program Administratorp. 149
Employee Assistance Program Coordinatorp. 149
Employee Assistance Counselorp. 150
Medical Review Officerp. 150
EAP Developmentp. 150
Decision Factorsp. 152
The Community Modelp. 153
In-House Modelp. 154
EAP Policyp. 155
Selecting an Employee Assistance Vendorp. 156
Clinical Servicesp. 157
A Phased Approachp. 158
Evaluating an EAP Vendorp. 160
Support and Involvementp. 163
Program Promotionp. 164
The Substance Abuse Professionalp. 165
The Face-To-Face Evaluationp. 167
Follow-Up Testingp. 169
Referralsp. 170
Confidentialityp. 171
A Complicating Factorp. 172
SAP Record Keepingp. 172
Payment for SAP Servicesp. 172
The EAP-Amenable Organizationp. 173
Treatmentp. 175
Dimensions of Drug Treatmentp. 175
Costs to Societyp. 175
Hospital Visits and Deathsp. 176
Treatment Trendsp. 177
Treatment Methodsp. 178
Types of Treatment Programsp. 178
Maintenance Treatmentp. 179
Outpatient Treatmentp. 179
Therapeutic Communitiesp. 180
Short-Term Residential Programsp. 180
Prison Programsp. 180
Treatment Medicationsp. 181
Behavioral Change Through Treatmentp. 182
Opiates: Abuse and Addictionp. 183
Administrationp. 184
Rushp. 184
Addiction and Dependencep. 185
Health Damagep. 186
HIV/AIDSp. 187
Heroin Treatmentp. 187
Detoxificationp. 188
Methadone Treatmentp. 188
LAAM and Other Medicationsp. 188
Behavioral Therapies for Heroin Addictionp. 189
Methamphetamine Abuse and Addictionp. 190
Administrationp. 191
Health Consequencesp. 192
Treatment for Methamphetamine Abusep. 194
Lessons From Prevention Researchp. 195
Myths Hinder Treatmentp. 197
The AIDS Connectionp. 198
Infection Ratesp. 199
HIV Among IDUsp. 199
Appendix Ap. 201
Executive Order 12564p. 201
Appendix Bp. 211
Resourcesp. 211
Hotlines, Helplines, and Web Sitesp. 211
National Resourcesp. 214
State and Territory Resourcesp. 220
Other State and Local Resourcesp. 311
Web Sitesp. 333
Appendix Cp. 337
Sample Policiesp. 337
Appendix Dp. 363
Announcement Aidsp. 363
Appendix Ep. 377
Employee Awareness Aidsp. 377
Crack and Cocainep. 377
Inhalant Abusep. 380
Heroinp. 382
LSDp. 385
Marijuanap. 386
Questions and Answers About Marijuanap. 390
Ecstasyp. 395
PCP (Phencyclidine)p. 397
Pain Medicationsp. 398
Ritalinp. 399
Rohypnol and GHBp. 400
Steroidsp. 401
Barbituratesp. 403
Depressantsp. 404
Drugs and Drivingp. 406
Marijuana and Learningp. 407
Opiates and Pregnancyp. 408
Peyote, Mescaline, and Psilocybinp. 410
Phencyclidine and Bizarre Behaviorp. 411
Stimulantsp. 413
Marijuana and Fertilityp. 414
Drug Mythsp. 416
Inhalants Are Everywherep. 417
LSD: The Ultimate Flashbackp. 419
Ice (Crystal Methamphetamine)p. 420
Prescription Drugsp. 421
Drugs and Stressp. 423
Drugs and Accidentsp. 424
The Truth About Drugsp. 426
Look-Alike and Act-Alike Drugsp. 427
Mixing Drugsp. 428
Appendix Fp. 431
Supervisor Aidsp. 431
Drug Abuse at Workp. 431
Dimensions of Workplace Drug Abusep. 433
Right and Wrong Actionsp. 434
The Tell-Tale Signs of Drug Abusep. 436
Indicators and Interventionp. 437
Appendix Gp. 441
Aids to Drug Testingp. 441
Instructions for Persons to Be Testedp. 441
Test Consent in Reasonable Cause and Post-Accident Situationsp. 442
Return to Duty Test Consentp. 443
Applicant's Consent to Be Testedp. 444
Employee's Consent to Be Testedp. 445
Employee's Voluntary Notice of Legal Drug Usep. 447
Notice of Positive Test Resultp. 448
Annual Summary of Test Results for Pipeline Operationsp. 449
Urine Specimen Collection Handbook for Federal Workplace Drug Testing Programsp. 450
Appendix Hp. 485
EAP Aidsp. 485
Statement of Employee Assistance Programp. 485
Directory of EAP Servicesp. 487
Directory of Substance Abuse Professionalsp. 520
Appendix Ip. 535
Glossaryp. 535
Indexp. 547
Table of Contents provided by Syndetics. All Rights Reserved.

ISBN: 9780750671873
ISBN-10: 0750671874
Audience: General
Format: Paperback
Language: English
Number Of Pages: 552
Published: 1st December 1999
Publisher: BUTTERWORTH-HEINEMANN
Country of Publication: US
Dimensions (cm): 23.34 x 15.27  x 2.9
Weight (kg): 0.73